Stromal cell-derived factor-1 chemokine gene variant in blood donors and chronic myelogenous leukemia patients

Journal of Clinical Laboratory Analysis

Volumn 21, Issue 1, 2007, Pages 49-54

  De Oliveira, Carlos Eduardo Coral ^a   Cavassin, Gabriela Gonçalves De Oliveira ^a   Perim, Aparecida De Lourdes ^a   Nasser, Thiago Franco ^a   De Oliveira, Karen Brajão ^a   Fungaro, Maria Helena Pelegrinelli ^a   Carneiro, Juliana Laino Do Val ^a   Watanabe, Maria Angelica Ehara ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

bcr abl; Chronic myeloid leukemia (CML); SDF1 chemokine

Indexed keywords

BCR ABL PROTEIN; HEMOGLOBIN; HYDROXYUREA; IMATINIB; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1; ABL BCR FUSION PROTEIN, HUMAN; ABL-BCR FUSION PROTEIN, HUMAN; ALPHA CHEMOKINE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADOLESCENT; AGED; ALLELE; ARTICLE; BASOPHIL; BLOOD DONOR; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC CONSERVATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PLURIPOTENT STEM CELL; ADULT; CASE CONTROL STUDY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD DONORS; CASE-CONTROL STUDIES; CHEMOKINES, CXC; CHILD; FEMALE; FUSION PROTEINS, BCR-ABL; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 34047233149     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20142     Document Type: Article

References (26)

1. Melo JV, Hughes TP, Apperley JF. Chronic myeloid leukemia. Hematology 2003;132-152.
2. Salesse S, Verfaillie CM. BCR/ABL-mediated increased expression of multiple known and novel genes that may contribute to the pathogenesis of chronic myelogenous leukemia. Mol Cancer Ther 2003;2:173-182.
3. Martinelli G, Soverini S, Rosti G, Cilloni D, Baccarani M. New tyrosine kinase inhibitors in chronic myeloid leukemia. Haematologica 2005;90:534-541.
4. Legdeur MC, Beelen RH, Schuurhuis GJ, et al. A functional study on the migration of human monocytes to human leukemic cell lines and the role of monocyte chemoattractant protein-1. Leukemia 1997;11:1904-1908.
5. + hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 1998;91:4523-1530.
6. Burger JA, Burger M, Kipps TJ. Chonic lymphocytic leukemia B cells express functional CXC4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 1999;94:3658-3667.
7. + progenitors to peripheral blood. J Exp Med 1997;185:111-120.
8. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996;184:1101-1109.
9. Lapidot T, Kollet O. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia 2002;10:1992-2003.
10. Winkler C, Modi W, Smith MW. Genetic restriction of AIDS pathogenesis by a SDF-1 chemokine gene variant. Science 1998;118:681-688.
11. Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 1993;261:600-603.
12. Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR. The HIV coreceptors CXCR4 and CCR5 are differently expressed and regulated on human lymphocytes. Proc Natl Acad Sci USA 1997;94:1925-1930.
13. Kirby LT, editor. DNA fingerprinting: an introduction. New York: Stocton Press; 1990.
14. Amarante MK, De Lucca FL, Oliveira CEC, et al. Expression Of noncoding mRNA in human blood cells activated with synthetic peptide of HIV. Blood Cells Mol Dis 2005;35:286-290.
15. Mazumder B, Seshadri V, Fox PL. Translational control by the 3′-UTR: the ends specify the means. Trends Biochem Sci 2003;2:91-98.
16. Thekkumkara TJ, Linas SL. Evidence for involvement of 3′-untranslated region in determining angiotensin II receptor coupling specificity to G-protein. Biochem J 2003;370:631-639.
17. Geay JF, Buet D, Zhang Y, et al. p210BCR-ABL inhibts SDF-1 chemotatic response via alteration of CXCR4 signaling and down-regulation of CXCR4 expression. Cancer Res 2005;65:2676-2683.
18. + cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1. Stem Cells 2002;20:259-266.
19. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996;382:635-638.
20. Cashman J, Clark-Lewis I, Eaves A, Eaves C. Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice. Blood 2002;99:792-799.
21. Fernandez-Luna JL. Bcr-Abl and inhibition of apoptosis in chronic myelogenous leukemia cells. Apoptosis 2000;5:315-318.
22. Mills KI, Benn P, Birnie GD. Does the breakpoint within the major breakpoint cluster region (M-bcr) influence the duration of the chronic phase in chronic myeloid leukemia? An analytical comparison of current literature. Blood 1991;78:1151-1161.
23. Shepherd P, Suffolk R, Halsey J, Allan N. Analysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival. Br J Haematol 1995;89:546-554.
24. Zaccaria A, Martineli G, Testoni N, et al. Does the type of BCR-ABL junction predict the survival of patients with chronic myeloid leukemia? Leuk Lymph 1995;16:231-236.
25. Iikura M, Miyamasu M, Yamaguchi M, et al. Chemokine receptors in human basophils: inducible expression of functional CXCR4. J Leukoc Biol 2001;70:113-120.
26. Cabral AR, Mancilla MM, Sanchez MA, et al. Analysis of Bcr-abl type transcript and its relationship with platelet count in Mexican patients with chronic myeloid leukemia. Gac Med Mex 2003;139:553-559.